Cognoptix

📍 Marlborough, United States🗓 Founded 2019👥 4 employees💰 Last funded Feb 2020
Medical Equipment Manufacturing🌐 cognoptix.com
Website LinkedIn
Cognoptix is pioneering a new way to see Alzheimer's disease (AD): a low-cost, practical and non-invasive eye scan that detects beta-amyloid deposits in the lens. Amyloid is the earliest biomarker of AD, and our system can detect it years or decades before amyloid appears in the brain.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
United States
1
Frequently asked questions
Who invested in Cognoptix?
Cognoptix has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Cognoptix last raise funding?
The most recent investment in Cognoptix recorded on gritt.io was in February 2020.
When was Cognoptix founded?
Cognoptix was founded in 2019.
What industry is Cognoptix in?
Cognoptix operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Cognoptix based?
Cognoptix is headquartered in Marlborough, United States.